Raghava Bio-Medicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 21-01-2025
- Paid Up Capital ₹ 1.00 M
as on 21-01-2025
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 16.81 Cr
as on 21-01-2025
- Revenue 22.76%
(FY 2022)
- Profit 11.38%
(FY 2022)
- Ebitda 17.24%
(FY 2022)
- Net Worth 55.53%
(FY 2022)
- Total Assets 15.06%
(FY 2022)
About Raghava Bio-Medicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹16.81 Cr.
Mohankrishna Ramachandra and Pavithra Sathyanarayana serve as directors at the Company.
- CIN/LLPIN
U51909KA2019PTC120755
- Company No.
120755
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jan 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Raghava Bio-Medicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohankrishna Ramachandra  | Director | 25-Jan-2019 | Current |
| Pavithra Sathyanarayana | Director | 25-Jan-2019 | Current |
Financial Performance of Raghava Bio-Medicals.
Raghava Bio-Medicals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 22.76% increase. The company also saw a substantial improvement in profitability, with a 11.38% increase in profit. The company's net worth Soared by an impressive increase of 55.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Raghava Bio-Medicals?
In 2023, Raghava Bio-Medicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Raghava Diagnostic Services Private LimitedActive 3 years 4 monthsMohankrishna Ramachandra and Pavithra Sathyanarayana are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 12 Jan 2023 | ₹5.00 Cr | Open |
Hdfc Bank Limited Creation Date: 21 Aug 2021 | ₹3.09 M | Open |
Others Creation Date: 31 Jul 2020 | ₹8.00 Cr | Open |
How Many Employees Work at Raghava Bio-Medicals?
Raghava Bio-Medicals has a workforce of 14 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Raghava Bio-Medicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raghava Bio-Medicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.